Literature DB >> 18694997

Divergent effects of hypoxia on dendritic cell functions.

Alessandra Mancino1, Tiziana Schioppa, Paola Larghi, Fabio Pasqualini, Manuela Nebuloni, I-Hsuan Chen, Silvano Sozzani, Jonathan M Austyn, Alberto Mantovani, Antonio Sica.   

Abstract

Dendritic cells (DCs) are professional antigen-presenting cells (APCs) that patrol tissues to sense danger signals and activate specific immune responses. In addition, they also play a role in inflammation and tissue repair. Here, we show that oxygen availability is necessary to promote full monocyte-derived DC differentiation and maturation. Low oxygen tension (hypoxia) inhibits expression of several differentiation and maturation markers (CD1a, CD40, CD80, CD83, CD86, and MHC class II molecules) in response to lipopolysaccharide (LPS), as well as their stimulatory capacity for T-cell functions. These events are paralleled by impaired up-regulation of the chemokine receptor CCR7, an otherwise necessary event for the homing of mature DCs to lymph nodes. In contrast, hypoxia strongly up-regulates production of proinflammatory cytokines, particularly TNFalpha and IL-1beta, as well as the inflammatory chemokine receptor CCR5. Subcutaneous injection of hypoxic DCs into the footpads of mice results in defective DC homing to draining lymph nodes, but enhanced leukocyte recruitment at the site of injection. Thus, hypoxia uncouples the promotion of inflammatory and tissue repair from sentinel functions in DCs, which we suggest is a safeguard mechanism against immune reactivity to damaged tissues.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18694997     DOI: 10.1182/blood-2008-02-142091

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  69 in total

Review 1.  HIF transcription factors, inflammation, and immunity.

Authors:  Asis Palazon; Ananda W Goldrath; Victor Nizet; Randall S Johnson
Journal:  Immunity       Date:  2014-10-16       Impact factor: 31.745

Review 2.  Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.

Authors:  Muhammad Zaeem Noman; Meriem Hasmim; Yosra Messai; Stéphane Terry; Claudine Kieda; Bassam Janji; Salem Chouaib
Journal:  Am J Physiol Cell Physiol       Date:  2015-08-26       Impact factor: 4.249

3.  Chemokine C-C motif receptor 5 and C-C motif ligand 5 promote cancer cell migration under hypoxia.

Authors:  Sensen Lin; Shuying Wan; Li Sun; Jialiang Hu; Dongdong Fang; Renping Zhao; Shengtao Yuan; Luyong Zhang
Journal:  Cancer Sci       Date:  2012-04-12       Impact factor: 6.716

Review 4.  Coordinated regulation of myeloid cells by tumours.

Authors:  Dmitry I Gabrilovich; Suzanne Ostrand-Rosenberg; Vincenzo Bronte
Journal:  Nat Rev Immunol       Date:  2012-03-22       Impact factor: 53.106

5.  The transcription factor NR4A3 controls CD103+ dendritic cell migration.

Authors:  Kiwon Park; Zbigniew Mikulski; Goo-Young Seo; Aleksander Y Andreyev; Paola Marcovecchio; Amy Blatchley; Mitchell Kronenberg; Catherine C Hedrick
Journal:  J Clin Invest       Date:  2016-11-07       Impact factor: 14.808

6.  Hypoxia-inducible factors: a central link between inflammation and cancer.

Authors:  Daniel Triner; Yatrik M Shah
Journal:  J Clin Invest       Date:  2016-08-15       Impact factor: 14.808

7.  Effects of TLR agonists on the hypoxia-regulated transcription factor HIF-1alpha and dendritic cell maturation under normoxic conditions.

Authors:  Rolf Spirig; Siamak Djafarzadeh; Tomas Regueira; Sidney G Shaw; Christophe von Garnier; Jukka Takala; Stephan M Jakob; Robert Rieben; Philipp M Lepper
Journal:  PLoS One       Date:  2010-06-07       Impact factor: 3.240

8.  Dendritic cells/natural killer cross-talk: a novel target for human immunodeficiency virus type-1 protease inhibitors.

Authors:  Maria Letizia Giardino Torchia; Elena Ciaglia; Anna Maria Masci; Laura Vitiello; Manuela Fogli; Andrea la Sala; Domenico Mavilio; Luigi Racioppi
Journal:  PLoS One       Date:  2010-06-10       Impact factor: 3.240

9.  HIF-1α influences myeloid cell antigen presentation and response to subcutaneous OVA vaccination.

Authors:  Tamara Bhandari; Joshua Olson; Randall S Johnson; Victor Nizet
Journal:  J Mol Med (Berl)       Date:  2013-05-19       Impact factor: 4.599

Review 10.  Modification of the tumor microenvironment as a novel target of renal cell carcinoma therapeutics.

Authors:  James H Finke; Pat A Rayman; Jennifer S Ko; Judy M Bradley; Sandra J Gendler; Peter A Cohen
Journal:  Cancer J       Date:  2013 Jul-Aug       Impact factor: 3.360

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.